Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

X-Change Corp. (XCHC) Is “One To Watch”

|Includes: Endocan CorporationA (ENDO)

X-Change Corp. specializes in cannabinoid based extracts and products that target medical cannabis, nutraceutical, cosmeceutical, and social usage solutions through multiple Phytiva brand product lines, products, and services. The company plans to launch a combination of retail and wholesale products, medical cannabis dispensaries, cannabis research in clinics and laboratories, and other legal state and foreign operations.

The company's Phytiva brand utilizes the unique and potent benefits of cannabinoids, the natural components found in the cannabis sativa L. plant, from which cannabis and hemp are produced. The company's formulations target not just the symptom, but the cause of critical ailments. Because the body responds extremely well to their properties, X-Change believes cannabinoids provide the ideal solution for better treatment and patient outcomes.

Respect for human life is a core value of the Phytiva brand, and X-Change believes that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. Phytiva uses the latest science and technology to study these possibilities with a key focus on making its carefully developed solutions accessible to all. First, all of Europe, the United States, and then beyond.

The staggering numbers of cases of HIV/AIDS, cancer, autoimmune disease, MRSA, diabetes, and a number of other ailments is X-Change's motivation to bring superior products to their respective markets, but the company is also targeting opportunities in the $350 billion personal care market. Leveraging its unique formulations and the branding abilities of its team, X-Change is well positioned to provide cannabinoid-based solutions to the mainstream market through multiple avenues.

Please see disclaimer on the QualityStocks website: